Maternal and Fetal Outcomes in Elective vs Emergency Cesarean Section
2026年6月11日 更新者：Abdelsalam Gomaa、Assiut University
Maternal and Fetal Outcomes in Elective and Emergency Cesarean Section in Women's Health Hospital
Cesarean section (CS) rates have increased substantially worldwide and in Egypt, where they now account for the majority of deliveries.
Maternal and neonatal outcomes may differ between elective and emergency CS.
Emergency cesarean sections are generally associated with higher maternal morbidity, including increased risks of postpartum hemorrhage, infection, blood transfusion, longer operative time, and prolonged hospital stay.
Neonatal outcomes following emergency CS may also be less favorable, with higher rates of low Apgar scores, respiratory distress, and NICU admission.
However, findings remain inconsistent across studies, highlighting the need for further prospective research to comprehensively compare maternal and fetal outcomes between elective and emergency cesarean deliveries.
研究概览
地位
尚未招聘
研究类型
观察性的
注册 (估计的)
210
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Alwany Elsenousy Eldreemy Elkasse, professor
- 电话号码：+2001225005036
- 邮箱：alwany.elsenousy@med.aun.edu.eg
研究联系人备份
- 姓名：Mohamed Bahaa Mohamed Ahmed, lecturer
- 电话号码：+200 10 22422960
- 邮箱：m.bahaa@med.aun.edu.eg
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
接受健康志愿者
不
取样方法
非概率样本
研究人群
Pregnant women undergoing cesarean section (elective or emergency) at Women's Health Hospital during the study period.
Eligible participants will include women with singleton pregnancies who meet the inclusion criteria and provide complete clinical data.
Maternal and neonatal outcomes will be assessed and compared between elective and emergency cesarean section groups.
描述
Inclusion Criteria:
- 1- Pregnant women undergoing cesarean section 2- Singleton pregnancy 3- Gestational age ≥ 28 weeks 4- Age 18-45 years
Exclusion Criteria:
- 1- Multiple pregnancy 2- Known fetal anomalies 3- Intrauterine fetal demise before cesarean section 4- Severe maternal comorbidities (e.g., cardiac disease, renal failure) 5- Rupture uterus 6- patients with placenta previa or accreta spectrum
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
• Maternal morbidity composite outcome • Neonatal morbidity composite outcome
大体时间：From cesarean delivery until hospital discharge (up to 7 days postpartum).
|
From cesarean delivery until hospital discharge (up to 7 days postpartum).
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Length of stay
大体时间：From cesarean delivery until maternal hospital discharge (days), up to 7 days postpartum.
|
From cesarean delivery until maternal hospital discharge (days), up to 7 days postpartum.
|
|
Operative time
大体时间：Assessed during cesarean section, from skin incision to skin closure (minutes).
|
Assessed during cesarean section, from skin incision to skin closure (minutes).
|
|
Infection rate
大体时间：From cesarean delivery through 6 weeks postpartum.
|
From cesarean delivery through 6 weeks postpartum.
|
|
Effect of confounding factors on neonatal outcomes (gestational age at delivery, type of anaesthesia)
大体时间：Assessed at birth and during neonatal hospitalization, up to 28 days after birth.
|
Assessed at birth and during neonatal hospitalization, up to 28 days after birth.
|
|
Effect of confounding factors on maternal outcomes (BMI)
大体时间：BMI assessed at admission for delivery; association with maternal outcomes evaluated from cesarean delivery through hospital discharge (up to 7 days postpartum).
|
BMI assessed at admission for delivery; association with maternal outcomes evaluated from cesarean delivery through hospital discharge (up to 7 days postpartum).
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
出版物和有用的链接
负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。
一般刊物
- Betran AP, Torloni MR, Zhang JJ, Gulmezoglu AM; WHO Working Group on Caesarean Section. WHO Statement on Caesarean Section Rates. BJOG. 2016 Apr;123(5):667-70. doi: 10.1111/1471-0528.13526. Epub 2015 Jul 22. No abstract available.
- Lucas DN, Yentis SM, Kinsella SM, Holdcroft A, May AE, Wee M, Robinson PN. Urgency of caesarean section: a new classification. J R Soc Med. 2000 Jul;93(7):346-50. doi: 10.1177/014107680009300703.
- Boerma T, Ronsmans C, Melesse DY, Barros AJD, Barros FC, Juan L, Moller AB, Say L, Hosseinpoor AR, Yi M, de Lyra Rabello Neto D, Temmerman M. Global epidemiology of use of and disparities in caesarean sections. Lancet. 2018 Oct 13;392(10155):1341-1348. doi: 10.1016/S0140-6736(18)31928-7.
- Khasawneh W, Obeidat N, Yusef D, Alsulaiman JW. The impact of cesarean section on neonatal outcomes at a university-based tertiary hospital in Jordan. BMC Pregnancy Childbirth. 2020 Jun 1;20(1):335. doi: 10.1186/s12884-020-03027-2.
- Souza JP, Gulmezoglu A, Lumbiganon P, Laopaiboon M, Carroli G, Fawole B, Ruyan P; WHO Global Survey on Maternal and Perinatal Health Research Group. Caesarean section without medical indications is associated with an increased risk of adverse short-term maternal outcomes: the 2004-2008 WHO Global Survey on Maternal and Perinatal Health. BMC Med. 2010 Nov 10;8:71. doi: 10.1186/1741-7015-8-71.
- Sandall J, Tribe RM, Avery L, Mola G, Visser GH, Homer CS, Gibbons D, Kelly NM, Kennedy HP, Kidanto H, Taylor P, Temmerman M. Short-term and long-term effects of caesarean section on the health of women and children. Lancet. 2018 Oct 13;392(10155):1349-1357. doi: 10.1016/S0140-6736(18)31930-5.
- Doke PP, Vaidya VM, Narula APS, Patil AV, Panchanadikar TM, Wagh GN, Iyengar KS. Relative risk of postpartum maternal morbidity among cesarean-delivered women: A multisite prospective cohort study in a large district, India. J Family Med Prim Care. 2022 Dec;11(12):7705-7712. doi: 10.4103/jfmpc.jfmpc_1292_22. Epub 2023 Jan 17.
- Abdel-Aleem H, Shaaban OM, Hassanin AI, Ibraheem AA. Analysis of cesarean delivery at Assiut University Hospital using the Ten Group Classification System. Int J Gynaecol Obstet. 2013 Nov;123(2):119-23. doi: 10.1016/j.ijgo.2013.05.011. Epub 2013 Jul 31.
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年7月1日
初级完成 (估计的)
2027年7月1日
研究完成 (估计的)
2027年9月1日
研究注册日期
首次提交
2026年6月11日
首先提交符合 QC 标准的
2026年6月11日
首次发布 (实际的)
2026年6月16日
研究记录更新
最后更新发布 (实际的)
2026年6月16日
上次提交的符合 QC 标准的更新
2026年6月11日
最后验证
2026年6月1日
更多信息
与本研究相关的术语
其他研究编号
- MF_CS_2026
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
未定
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.